External Scientific Engagement Director, Obesity

AstraZeneca is advancing a tailored approach to Obesity and Weight Management, uniting science, medical and commercial excellence to deliver durable outcomes, reduce cardiometabolic risk and protect organs. Our pipeline is moving with purpose and includes next generation oral and injectable therapies that prioritises tolerability, durability and quality of life. Are you ready to be at the forefront of medical innovation? As the director External Scientific Engagement for Obesity, you'll play a pivotal role in shaping the future of obesity care. This is your chance to use your expertise to make a real impact on patients' lives. Join us in our mission to transform the patient journey, from prevention to diagnosis, and beyond. Are you ready to take on this challenge? 

The External Scientific Engagement Director Obesity is a strategic and visionary medical leader across the BioPharmaceutical Medical (BPM) Cardiovascular, Renal and Metabolism (CVRM) organization, who drives AstraZeneca’s external leadership, including partnerships with key external experts (KEEs) and scientific societies to improve healthcare delivery and patient care around the world.   The ESE Director is a key driver within and across brand in the obesity and related diseases area, working cross functionally with strong entrepreneurial skills to support the CVRM portfolio and addressing unmet medical needs through our CVRM external engagement strategies.   

Main duties and responsibilities:  

• Drive partnerships with scientific societies and healthcare system decision makers to improve healthcare delivery around the world, both from a brand specific and CVRM-wide perspective. 

• Identify and lead strategic advocacy and engagement plans with KEEs to develop experts who can participate in global, regional and local medical activities outlined in the CVRM Strategic Plans. 

• Strategically drive external initiatives through grants and sponsorships that support patient engagement, disease state education, policy issues, that are aligned with franchise and business ambition.  

• Map clinical guideline across the CVRM space, along with preparation and communication around key updates, and create plans to drive clinical guideline implementation at global <